NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Chronic HF and comorbid impairment of kidney function who had a recent HF event to evaluate
the effect of balcinrenone/dapagliflozin versus dapagliflozin alone on HF events and cardiovascular (CV) death
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.